Cas No.: | 1316214-52-4 |
名称: | 5-Pyrimidinecarboxamide,2-(diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]- |
别名: | Rocilinostat; ACY1215; ACY 1215,Ricolinostat |
SMILES: | O=C(C1=CN=C(N(C2=CC=CC=C2)C3=CC=CC=C3)N=C1)NCCCCCCC(NO)=O |
分子式: | C24H27N5O3 |
分子量: | 433.5 |
纯度: | |
保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | |
In Vivo: | |
In Vitro: | |
References: | ACY-1215 is a hydroxamic acid derivative. ACY-1215 is 12-, 10-, and 11-fold less active against HDAC1, HDAC2, and HDAC3 (class I HDACs), respectively. ACY-1215 has minimal activity (IC50 > 1μM) against HDAC4, HDAC5, HDAC7, HDAC9, HDAC11, Sirtuin1, and Sir |
Kinase Assay: | |
Cell Assay: | |
Animal Administration: | |
References: |